US 11376313
Cancer treatment
granted A61KA61K2300/00A61K38/47
Quick answer
US patent 11376313 (Cancer treatment) held by Propanc Pty Ltd expires Mon Jun 30 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Propanc Pty Ltd
- Grant date
- Tue Jul 05 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 30 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K2300/00, A61K38/47, A61K38/4826, A61P